Wyeth division buys Thiakis
Wyeth Pharmaceuticals, a division of Wyeth, has acquired private equity-backed Thiakis, a privately held biotechnology company based in the UK, for an initial payment of $30 million (£20 million).
News
Wyeth Pharmaceuticals, a division of Wyeth, has acquired private equity-backed Thiakis, a privately held biotechnology company based in the UK, for an initial payment of $30 million (£20 million).
News
Partner content
Accounting and Finance Software
Accounting and Finance Software